Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
232.3 INR | -4.99% | -26.48% | -19.00% |
Sales 2022 | 1.37B 16.44M | Sales 2023 | 2.39B 28.6M | Capitalization | 58.2B 697M |
---|---|---|---|---|---|
Net income 2022 | -2.03B -24.36M | Net income 2023 | -2.23B -26.66M | EV / Sales 2022 | 59.3 x |
Net Debt 2022 | 663M 7.94M | Net cash position 2023 | 3.87B 46.33M | EV / Sales 2023 | 22.8 x |
P/E ratio 2022 |
-38.4
x | P/E ratio 2023 |
-22.9
x | Employees | 407 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25.39% |
Latest transcript on Sun Pharma Advanced Research Company Limited
1 day | -4.99% | ||
1 week | -26.48% | ||
Current month | -36.93% | ||
1 month | -36.93% | ||
3 months | -37.35% | ||
6 months | +1.75% | ||
Current year | -19.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 14-04-23 | |
Chetan Rajpara
DFI | Director of Finance/CFO | - | 17-01-31 |
Chairman | 68 | 06-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 06-02-28 | |
Director/Board Member | 67 | 06-02-28 | |
Director/Board Member | 70 | 14-10-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | -0.10% | - | |
0.00% | 34 M€ | +1.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 232.3 | -4.99% | 410,800 |
24-04-29 | 244.5 | -4.99% | 4,763,671 |
24-04-26 | 257.4 | -5.00% | 592,866 |
24-04-25 | 270.9 | -5.00% | 14,322,210 |
24-04-24 | 285.2 | -5.00% | 216,781 |
Delayed Quote NSE India S.E., April 30, 2024 at 07:42 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-19.00% | 903M | |
+34.00% | 704B | |
+29.29% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+13.79% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- SPARC Stock